
They’re in it together…


The development and rollout of COVID-19 vaccines has minted at least nine new billionaires in the pharma industry, whose new combined wealth is enough to buy shots for a staggering 780 million people in low-income nations.
Nine executives from Moderna, BioNTech, ROVI and CanSino Biologics have hugely profited from the pandemic that has so far killed 3.4 million people worldwide, as their individual wealth soared past the billion-dollar mark over the last year.
The rich list was compiled by the People’s Vaccine Alliance, a campaign group that includes Oxfam, UNAIDS, Global Justice Now and Amnesty International, using the Forbes Rich List.





Schuler’s next big bet is the Schuler Access Initiative, his plan for increasing enrollment for undocumented and low-income students at the country’s top liberal arts colleges. Partnering with up to 20 liberal arts schools, including Carleton, he aims to raise another $500 million in matching funds for a total of $1 billion. That money will go to colleges that will commit to increasing their enrollment of undocumented and financially needy students by two to six percent over ten years. Given the very low number of undocumented students at many universities, Schuler says the program stands to more than double their ranks if it’s successful.
“Their parents were unwilling to accept the status quo back home,” he says of the students. “This next generation is going to be extremely successful, particularly if we let them eventually become citizens, because they’re much more motivated.”
A search for “who is the most powerful doctor in the world?” on Google provides the answer as Bill Gates.
In response to the query, the entire first page of results lists Bill Gates, who isn’t even a doctor, based on a Politico article from 2017 detailing Gates’ ‘sway’ over the World Health Organisation.
The article notes that Gates has donated $2.4 billion to the WHO since 2000, a figure that has increased in the five years since the piece was penned.

You must be logged in to post a comment.